IL6 and breast carcinoma: It has been described that melatonin, in co-cultures of human breast cancer cells and 3T3-L1 fibroblasts, decreases the levels of TNFα, IL-11, and IL-6 in the culture media and downregulates TNFα, IL-11, and IL-6 mRNA expression in both types of cells [52].